Pharmacovigilance: A Practical Approach
Editat de Thao Doan, Linda Scarazzini, Cheryl Renz, Fabio Lievano, Mondira Bhattacharyaen Limba Engleză Paperback – 2 aug 2018
Preț: 547.74 lei
Preț vechi: 576.58 lei
-5% Nou
Puncte Express: 822
Preț estimativ în valută:
104.83€ • 108.89$ • 87.07£
104.83€ • 108.89$ • 87.07£
Carte disponibilă
Livrare economică 13-27 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 34.84 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323581165
ISBN-10: 0323581161
Pagini: 228
Ilustrații: 100 illustrations (100 in full color)
Dimensiuni: 191 x 235 x 16 mm
Greutate: 0.48 kg
Editura: Elsevier
ISBN-10: 0323581161
Pagini: 228
Ilustrații: 100 illustrations (100 in full color)
Dimensiuni: 191 x 235 x 16 mm
Greutate: 0.48 kg
Editura: Elsevier
Cuprins
Introduction
1. Does Regulation Drive Science or Does Science Drive Regulation?
2. Role of Epidemiology in Pharmaceutical Industry
3. Real World Epidemiologic Studies and Patient Registries
Section III. Benefit-Risk in the Drug Development Life Cycle
4. Signal Management and Methods of Signal Detection
5. Causality Assessment and Examples of Adverse Drug Reactions (Drug Induced Liver Injury, Skin, Major Adverse Cardiac Events and Renal)
6. Product Safety Monitoring in Clinical Trials
7. Benefit-Risk Assessments
8. Communicating benefit risk
9. Pharmacovigilance and Medical Devices
10. Vaccine Safety Surveillance
11. Pharmacovigilance in Special Populations (Pediatrics and Elderly)
12. Pharmacovigilance in Pregnancy
13. Impact and Implications of Technology on Pharmacovigilance
14. The Future of Pharmacovigilance
1. Does Regulation Drive Science or Does Science Drive Regulation?
2. Role of Epidemiology in Pharmaceutical Industry
3. Real World Epidemiologic Studies and Patient Registries
Section III. Benefit-Risk in the Drug Development Life Cycle
4. Signal Management and Methods of Signal Detection
5. Causality Assessment and Examples of Adverse Drug Reactions (Drug Induced Liver Injury, Skin, Major Adverse Cardiac Events and Renal)
6. Product Safety Monitoring in Clinical Trials
7. Benefit-Risk Assessments
8. Communicating benefit risk
9. Pharmacovigilance and Medical Devices
10. Vaccine Safety Surveillance
11. Pharmacovigilance in Special Populations (Pediatrics and Elderly)
12. Pharmacovigilance in Pregnancy
13. Impact and Implications of Technology on Pharmacovigilance
14. The Future of Pharmacovigilance